Lord, Abbett & Co
ZBH icon

Lord, Abbett & Co’s Zimmer Biomet ZBH Stock Holding History

Lord, Abbett & Co’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-499,817
Closed -$71M – 694
2021
Q3 		$71M Sell
499,817
-62,471
-11% -$9.19M 0.17% 182
2021
Q2 		$87.8M Buy
562,288
+91,525
+19% +$14.8M 0.21% 140
2021
Q1 		$73.2M Buy
470,763
+361,605
+331% +$56M 0.19% 178
2020
Q4 		$16.3M Buy
+109,158
New +$15.4M 0.04% 441
2020
Q2 		– Sell
-163,367
Closed -$16M – 702
2020
Q1 		$16M Sell
163,367
-17,317
-10% -$2.27M 0.07% 352
2019
Q4 		$26.3M Buy
180,684
+3,500
+2% +$483K 0.09% 344
2019
Q3 		$23.6M Sell
177,184
-4,920
-3% -$636K 0.08% 378
2019
Q2 		$20.8M Sell
182,104
-117,523
-39% -$13.8M 0.07% 412
2019
Q1 		$37.1M Sell
299,627
-34,711
-10% -$3.94M 0.12% 264
2018
Q4 		$33.7M Buy
334,338
+60,255
+22% +$6.78M 0.12% 260
2018
Q3 		$35M Sell
274,083
-2,678
-1% -$318K 0.1% 350
2018
Q2 		$29.9M Sell
276,761
-78,383
-22% -$8.53M 0.09% 367
2018
Q1 		$37.6M Sell
355,144
-8,549
-2% -$993K 0.11% 292
2017
Q4 		$42.6M Sell
363,693
-30,797
-8% -$3.48M 0.12% 269
2017
Q3 		$44.8M Buy
394,490
+349,788
+782% +$40.4M 0.13% 248
2017
Q2 		$5.57M Buy
44,702
+1,236
+3% +$147K 0.02% 748
2017
Q1 		$5.15M Buy
43,466
+824
+2% +$93.4K 0.02% 740
2016
Q4 		$4.27M Sell
42,642
-21,115
-33% -$2.26M 0.01% 767
2016
Q3 		$8.05M Sell
63,757
-1,236
-2% -$153K 0.02% 637
2016
Q2 		$7.6M Buy
+64,993
New +$7.36M 0.02% 631
2015
Q3 		– Sell
-39,701
Closed -$4.21M – 968
2015
Q2 		$4.21M Sell
39,701
-150,857
-79% -$16.7M 0.01% 798
2015
Q1 		$21.7M Sell
190,558
-48,358
-20% -$5.52M 0.06% 467
2014
Q4 		$26.3M Buy
238,916
+131,646
+123% +$13.9M 0.07% 407
2014
Q3 		$10.5M Buy
+107,270
New +$10.6M 0.03% 593

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Lord, Abbett & Co's ZBH Position: Q4 2021 in Review

Lord, Abbett & Co sold out of Zimmer Biomet (ZBH) in Q4 2021, closing a stake of 499,817 shares — an estimated $71M sold.

Lord, Abbett & Co first reported a position in ZBH in Q3 2014 and held it in 24 quarters. The position peaked at $87.8M in Q2 2021. 998 funds tracked by Wall St. Rank hold ZBH as of Q4 2021.

  • Lord, Abbett & Co reported no remaining Zimmer Biomet position as of Q4 2021 after selling out during the quarter.
  • Lord, Abbett & Co sold 499,817 Zimmer Biomet shares in Q4 2021, an estimated $71M.
  • Lord, Abbett & Co first reported a position in Zimmer Biomet in Q3 2014 and held it in 24 quarters.
  • Lord, Abbett & Co's Zimmer Biomet position peaked at $87.8M in Q2 2021.
  • 998 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2021.

Based on Lord, Abbett & Co's 13F filing for Q4 2021, filed 11 Feb 2022.